Overview

Etanercept in Kawasaki Disease

Status:
Unknown status

Trial end date:
2018-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Etanercept (Enbrel) when used in conjunction with IVIG and aspirin, improves treatment response to IVIG in patients with Kawasaki Disease. Funding Source- FDA/OOPD

Phase:

Phase 2

Details

Lead Sponsor:

Michael Portman

Collaborator:

Amgen

Treatments:

Etanercept